The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate – a randomised controlled trial

BACKGROUND: Clomiphene citrate (CC) is first line treatment in women with World Health Organization (WHO) type II anovulation and polycystic ovary syndrome (PCOS). Whereas 60% to 85% of these women will ovulate on CC, only about one half will have conceived after six cycles. If women do not conceive...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nahuis, Marleen J, Weiss, Nienke S, van der Veen, Fulco, Mol, Ben Willem J, Hompes, Peter G, Oosterhuis, Jur, Lambalk, Nils B, Smeenk, Jesper MJ, Koks, Carolien AM, van Golde, Ron JT, Laven, Joop SE, Cohlen, Ben J, Fleischer, Kathrin, Goverde, Angelique J, Gerards, Marie H, Klijn, Nicole F, Nekrui, Lizka CM, van Rooij, Ilse AJ, Hoozemans, Diederik A, van Wely, Madelon
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828011/
https://ncbi.nlm.nih.gov/pubmed/24160333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6874-13-42
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados